ArticleMolecular therapy. Nucleic acids2023

Subretinal gene therapy delays vision loss in a Bardet-Biedl Syndrome type 10 mouse model.

Ying Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.